Patent infringement litigation between Pfizer and Ranbaxy over Lipitor will continue in Finland, Spain, Portugal, Denmark and Romania.

• 专利侵权诉讼之间的辉瑞和兰伯西超过立普妥将继续在芬兰，西班牙，葡萄牙，丹麦和罗马尼亚。